237 related articles for article (PubMed ID: 8993834)
21. Granulocytic differentiation induced by retinoic acid in HL-60 cells is associated with changes in adenylate cyclase activity.
Thomas G; Chomienne C; Balitrand N; Schaison G; Abita JP; Baulieu EE
Anticancer Res; 1986; 6(4):857-60. PubMed ID: 3092726
[TBL] [Abstract][Full Text] [Related]
22. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
23. Imbalance in the nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell-cycle phase, proliferation, differentiation, and transformation.
de Korte D; Haverkort WA; de Boer M; van Gennip AH; Roos D
Cancer Res; 1987 Apr; 47(7):1841-7. PubMed ID: 3469022
[TBL] [Abstract][Full Text] [Related]
24. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
Cheng HW; Armstrong RD; Sadée W
Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
[TBL] [Abstract][Full Text] [Related]
25. Guanine nucleotide exchange-independent activation of Gs protein by beta2-adrenoceptor.
Ugur O; Oner SS; Molinari P; Ambrosio C; Sayar K; Onaran HO
Mol Pharmacol; 2005 Sep; 68(3):720-8. PubMed ID: 15933218
[TBL] [Abstract][Full Text] [Related]
26. A role for the subcellular localization of Bax in differentiation-induced resistance to apoptosis in HL-60 cells.
Abdelhaleem M
Anticancer Res; 2002; 22(1A):177-81. PubMed ID: 12017283
[TBL] [Abstract][Full Text] [Related]
27. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
York RD; Yao H; Dillon T; Ellig CL; Eckert SP; McCleskey EW; Stork PJ
Nature; 1998 Apr; 392(6676):622-6. PubMed ID: 9560161
[TBL] [Abstract][Full Text] [Related]
28. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
Huff SY; Quilliam LA; Cox AD; Der CJ
Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
[TBL] [Abstract][Full Text] [Related]
29. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.
Kharbanda SM; Sherman ML; Spriggs DR; Kufe DW
Cancer Res; 1988 Nov; 48(21):5965-8. PubMed ID: 2901907
[TBL] [Abstract][Full Text] [Related]
30. Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm.
Lenzen C; Cool RH; Prinz H; Kuhlmann J; Wittinghofer A
Biochemistry; 1998 May; 37(20):7420-30. PubMed ID: 9585556
[TBL] [Abstract][Full Text] [Related]
31. High-frequency 94 GHz ENDOR characterization of the metal binding site in wild-type Ras x GDP and its oncogenic mutant G12V in frozen solution.
Bennati M; Hertel MM; Fritscher J; Prisner TF; Weiden N; Hofweber R; Spörner M; Horn G; Kalbitzer HR
Biochemistry; 2006 Jan; 45(1):42-50. PubMed ID: 16388579
[TBL] [Abstract][Full Text] [Related]
32. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
[TBL] [Abstract][Full Text] [Related]
33. Dimethyl sulphoxide alters mitogen induced production of diacylglycerol and GTP-binding to plasma membranes in mouse embryo fibroblasts.
Ganapathy P; Shanmugam G
Biochem Mol Biol Int; 1995 Apr; 35(4):739-48. PubMed ID: 7627124
[TBL] [Abstract][Full Text] [Related]
34. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts.
Bossù P; Vanoni M; Wanke V; Cesaroni MP; Tropea F; Melillo G; Asti C; Porzio S; Ruggiero P; Di Cioccio V; Maurizi G; Ciabini A; Alberghina L
Oncogene; 2000 Apr; 19(17):2147-54. PubMed ID: 10815806
[TBL] [Abstract][Full Text] [Related]
35. Ras regulation by reactive oxygen and nitrogen species.
Heo J; Campbell SL
Biochemistry; 2006 Feb; 45(7):2200-10. PubMed ID: 16475808
[TBL] [Abstract][Full Text] [Related]
36. The guanine nucleotide-binding switch in three dimensions.
Vetter IR; Wittinghofer A
Science; 2001 Nov; 294(5545):1299-304. PubMed ID: 11701921
[TBL] [Abstract][Full Text] [Related]
37. Relevance of the kinetic equilibrium of forces to the control of the cell cycle by Ras proteins.
Becker EW
Biol Chem; 2004 Jan; 385(1):41-7. PubMed ID: 14977045
[TBL] [Abstract][Full Text] [Related]
38. Effects of TPA, bryostatin 1, and retinoic acid on PO-B, AP-1, and AP-2 DNA binding during HL-60 differentiation.
Davis AF; Meighan-Mantha RL; Riegel AT
J Cell Biochem; 1997 Jun; 65(3):308-24. PubMed ID: 9138088
[TBL] [Abstract][Full Text] [Related]
39. Real-time in vitro measurement of intrinsic and Ras GAP-mediated GTP hydrolysis.
Shutes A; Der CJ
Methods Enzymol; 2006; 407():9-22. PubMed ID: 16757310
[TBL] [Abstract][Full Text] [Related]
40. Tiazofurin: molecular and clinical action.
Weber G; Prajda N; Abonyi M; Look KY; Tricot G
Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
